Cargando…

Enhanced H(2) production from dehydrogenation of sodium borohydride over the ternary Co(0.97)Pt(0.03)/CeO(x) nanocomposite grown on CGO catalytic support

The development of low-cost materials for the 100% dehydrogenation of metal hydrides is highly essential to vitalize the chemical hydride-based hydrogen economy. In this context, the ternary Co–Ce–Pt nanocomposite immobilized on functionalized catalytic support CGO is synthesized by the one step che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotkondawar, Abhay Vijay, Rayalu, Sadhana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119289/ https://www.ncbi.nlm.nih.gov/pubmed/35693040 http://dx.doi.org/10.1039/c9ra10742h

Ejemplares similares

Si(0.97)Ge(0.03) microelectronic thermoelectric generators with high power and voltage densities
por: Dhawan, Ruchika, et al.
Publicado: (2020)

Metal-Semiconductor AsSb-Al(0.6)Ga(0.4)As(0.97)Sb(0.03) Metamaterial
por: Bert, Nikolay, et al.
Publicado: (2022)

Weak antilocalization, spin–orbit interaction, and phase coherence length of a Dirac semimetal Bi(0.97)Sb(0.03)
por: Salawu, Yusuff Adeyemi, et al.
Publicado: (2022)

Performance Optimization of Pb(0.97)La(0.03)Sc(0.45)Ta(0.45)Ti(0.1)O(3) Ceramics by Annealing Process
por: Su, Zihan, et al.
Publicado: (2023)

Giant enhancement in critical current density, up to a hundredfold, in superconducting NaFe(0.97)Co(0.03) As single crystals under hydrostatic pressure
por: Shabbir, Babar, et al.
Publicado: (2015)

Structural Transitions in Nanosized Zn(0.97)Al(0.03)O Powders under High Pressure Analyzed by in Situ Angle-Dispersive X-ray Diffraction
por: Lin, Chih-Ming, et al.
Publicado: (2016)

Reduced Defects and Enhanced Performance of (FAPbI(3))(0.97)(MAPbBr(3))(0.03)-Based Perovskite Solar Cells by Trimesic Acid Additives
por: Quy, Hoang V., et al.
Publicado: (2021)

High-pressure synthetic (Na(0.97)Mg(0.03))(Mg(0.43)Fe(0.17) (3+)Si(0.40))Si(2)O(6), with six-coordinated silicon, isostructural with P2/n omphacite
por: Posner, Esther S., et al.
Publicado: (2012)

Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis
por: Carruthers, Jean, et al.
Publicado: (2016)

LEP Design And Performance For Delta Q = 0.03
por: Keil, Eberhard
Publicado: (1979)

Treatment of balanitis of Zoon's with tacrolimus 0.03% ointment
por: Chander, Ram, et al.
Publicado: (2009)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Preparation and Properties of Ce(0.8)Sm(0.16)Y(0.03)Gd(0.01)O(1.9)-BaIn(0.3)Ti(0.7)O(2.85) Composite Electrolyte
por: Wang, Yajun, et al.
Publicado: (2022)

Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%)
por: Gheith, Moataz E, et al.
Publicado: (2008)

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023)

Giant Negative Electrocaloric Effect in Anti-Ferroelectric (Pb(0.97)La(0.02))(Zr(0.95)Ti(0.05))O(3) Ceramics
por: Zhao, Ying-Cheng, et al.
Publicado: (2019)

Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
por: Goldberg, Ivan, et al.
Publicado: (2014)

Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: A patient-use study
por: Paolera, Mauricio D, et al.
Publicado: (2008)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
por: Chang-Lin, Joan-En, et al.
Publicado: (2011)

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
por: Day, Douglas G, et al.
Publicado: (2013)

Study of diffuse phase transition and relaxor ferroelectric behavior of Ba(0.97)Bi(0.02)Ti(0.9)Zr(0.05)Nb(0.04)O(3) ceramic
por: Raddaoui, Z., et al.
Publicado: (2019)

Correlation of crystal structure and optical properties of Ba(0.97)Nd(0.0267)Ti((1-x))W(x)O(3) perovskite
por: Raddaoui, Z., et al.
Publicado: (2018)

Borohydride-containing coordination polymers: synthesis, air stability and dehydrogenation
por: Kadota, Kentaro, et al.
Publicado: (2019)

Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice
por: Pfennigsdorf, Stefan, et al.
Publicado: (2016)

Assessment of 5% Amlexanox, 0.1% Triamcinolone Acetonide and 0.03% Tacrolimus in the Management of Oral Lichen Planus
por: AlMutairi, Mohammed, et al.
Publicado: (2023)

Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis
por: Hazarika, Ajit Kumar, et al.
Publicado: (2015)

Successful Treatment of Recalcitrant Granuloma Gluteale Infantum with Topical Tacrolimus 0.03% Ointment
por: Leung, Alexander K. C., et al.
Publicado: (2021)

Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03%
por: Georgakopoulou, Eleni, et al.
Publicado: (2021)

Mixed-metal phosphates K(1.64)Na(0.36)TiFe(PO(4))(3) and K(0.97)Na(1.03)Ti(1.26)Fe(0.74)(PO(4))(3) with a langbeinite framework
por: Zatovsky, Igor V., et al.
Publicado: (2021)

Comparing the Efficacy of Latanoprost (0.005%), Bimatoprost (0.03%), Travoprost (0.004%), and Timolol (0.5%) in the Treatment of Primary Open Angle Glaucoma
por: Mishra, Deepak, et al.
Publicado: (2014)

Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
por: Xu, Kai Man, et al.
Publicado: (2022)

(La(0.97)RE(0.01)Yb(0.02))(2)O(2)S Nanophosphors Converted from Layered Hydroxyl Sulfate and Investigation of Upconversion Photoluminescence (RE=Ho, Er)
por: Li, Ji-Guang, et al.
Publicado: (2017)

Small field models of inflation that predict a tensor-to-scalar ratio $r=0.03$
por: Wolfson, Ira, et al.
Publicado: (2019)

Kaposi's Varicelliform Eruption During Long-term Treatment of Rosacea with 0.03% Tacrolimus Ointment
por: Chen, Qi-Quan, et al.
Publicado: (2015)

Topical Treatment of Eyebrow Hypotrichosis with Bimatoprost 0.03% Solution: Case Report and Literature Review
por: Riahi, Ryan R, et al.
Publicado: (2018)

Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis
por: Bhargava, Rahul, et al.
Publicado: (2019)

Effect of topical nitric oxide donors 0.03% nitroglycerin and 0.1% hydralazine on intraocular pressure in healthy canine eyes
por: Wilcox, Parker A., et al.
Publicado: (2022)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
por: Schnober, Dietmar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uqvj5i24pv39nfbsbt54kjv5tu